Full text is available at the source.
Abstract
The association between glucagon-like peptide-1 receptor agonists (GLP-1RA) and hematologic malignancies is relatively underexplored.
- GLP-1RA are commonly used for diabetes and obesity management.
- Growing literature exists on GLP-1RA and obesity-related cancers.
- Limited research has focused specifically on the link between GLP-1RA use and blood cancers.
Simplified